Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

469.74
Delayed Data
As of Aug 21
 +1.76 / +0.38%
Today’s Change
325.35
Today|||52-Week Range
543.55
+27.96%
Year-to-Date

Today’s Trading

Previous close467.98
Today’s open467.75
Day’s range467.43 - 472.49
Volume510,675
Average volume (3 months)891,633
Market cap$50.3B
Dividend yield--
Data as of 08/21/2017

Growth & Valuation

Earnings growth (last year)+39.49%
Earnings growth (this year)+31.01%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)+18.44%
P/E ratio47.1
Price/Sales8.79
Price/Book11.19

Competitors

 Today’s
change
Today’s
% change
SHPGShire-4.70-3.23%
VRTXVertex Pharmaceutica...+0.88+0.59%
BAXBaxter International...+0.24+0.39%
ZTSZoetis Inc+0.60+0.99%
Data as of 08/21/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)$3.85
Annual revenue (last year)$4.9B
Annual profit (last year)$895.5M
Net profit margin18.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer &
Senior VP-Finance
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts